The FDA approves suzetrigine, a non-opioid pain medication, offering a safer alternative to opioids for pain management, ...

Rapidly spreading, harrowing and potentially lethal, a necrotizing soft tissue infection — so-called flesh-eating disease — ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...

Here is some info from Ohio State – improving lives through excellence in research, education and patient care.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...

The U.S. Food and Drug Administration (FDA) on Thursday approved Journavx, the first new class of pain medication in more ...

After learning you have prediabetes, you may work with your healthcare team to make changes to your eating style, weight ...

A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...

Cigna To Reform Prior Authorization, Provider Services In 2025 The Cigna Group will spend up to $150 million to reform its prior authorization, patient advocacy and provider services this year, CEO ...